Jasmin Hundal, Chair of Hematology-Oncology Research Fellowship Working Group at Cleveland Clinic, shared a post on LinkedIn:
“Our new study, ‘Disparities in Breast Cancer Diagnosis, Treatment, and Outcomes Among South Asian American Women’ was published today in Cancers.
Authors: Jasmin Hundal, Ishan Gupta, Ashiya Loomba, Yanwen Chen, Halle Moore, Sudipto Mukherjee, Abhay Singh
Read The Full Article.
South Asian Americans are the fastest-growing immigrant population in the United States, yet they remain underrepresented in breast cancer research and are often grouped within the broader Asian American category.
This makes it difficult to identify population-specific differences in cancer presentation, treatment, and outcomes.
Using the National Cancer Database, we evaluated more than 2.3 million women with breast cancer, including more than 20,000 South Asian American women.
We found that South Asian American women were diagnosed at younger ages, had higher proportions of HER2-positive and triple-negative breast cancers, and experienced longer time to treatment initiation. Despite these differences, they had more favorable long-term overall survival.
These findings highlight why disaggregated data matter.
This may be particularly important as we gain a better understanding of the distinct cardiometabolic risk profile of South Asian populations, including a higher burden of diabetes, visceral adiposity, insulin resistance, and cardiovascular disease.
Better representation and more granular data will be important to understand how biological, metabolic, clinical, and social factors together shape breast cancer outcomes in this population.
Grateful to my coauthors Ishan Gupta, Ashiya Loomba, Yanwen Chen and my mentors Halle Moore, Sudipto Mukherjee, and Abhay Singh.”
You can also read: Rare Triple-Negative Breast Cancer Is Not One Diseas